{'Year': '2022', 'Month': 'Jun', 'Day': '27'}
Influence of <i>CYP2C19*17</i> Genetic Polymorphism on the Steady-State Concentration of Escitalopram in Patients with Recurrent Depressive Disorder.
Escitalopram is commonly prescribed to patients with recurrent depressive disorder. Some of them do not show adequate response to treatment with escitalopram, while many of them experience adverse drug reactions.